Philippe Tramoy - Profile and Investment Details

Investor Profile

Philippe Tramoy is a Venture Capital, Investor, Private Equity Firm based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as FeetMe, ASTON iTrade Finance, TIBOT Technologies, Intento Design, Animab, machtfit, Veact, Anaeropharma Science, JobTeaser, Skinjay, Cambrooke Therapeutics, Dermala, Testbirds, Push Doctor, Eligo Bioscience, LARQ, PEP-Therapy, Ervaccine Technologies, Tubulis, MaaT Pharma, TransferGo, Virovet, HARDLOOP, Domain Therapeutics, Botfuel, Foodsmart by Zipongo, Citryll, Keen Eye Technologies, Yelloan, MDoloris Medical Systems, DayTwo, MilliDrop, Izicap, TargEDys, Presto Engineering, Pitchy, Federation Bio, CryoCapCell, NovoBind, Clim8, Corwave, LiMM Therapeutics, Siolta Therapeutics, Axial Biotherapeutics, A-Mansia Biotech, Microbiotica, Mailjet, Actronika, ENTEROME, MycoTechnology, fromAtoB, Launchmetrics, BIOMx, Indexima, Business Table, Mint Solutions, HomeRez, Vedanta Biosciences, Expensya, IDnow, Studitemps, MedinCell, payleven, Saagie, Chronotruck, Scipio Bioscience, Galecto, Hepster, String Bio, LNC Therapeutics, MOVE ‘N SEE, wealthpilot, Opencell Software, HorseCom, Il Etait Un Fruit, FIRE1. Over time, Philippe Tramoy has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Philippe Tramoy is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Billing, Accounting, Women Founded, Enterprise Software, Android, Women Led, Life Science, Information Technology (IT), Biotech, Medical Device, Software, Manufacturing, Healthcare, Biotechnology, InsurTech, FinTech, Insurance, Financial Services, Medical, SaaS, Six Sigma, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Philippe Tramoy, as their portfolio suggests a familiarity and interest in this area.

Understanding Philippe Tramoy’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.